The fate of a popular health care reform — one with a 70% approval rating in a late 2018 Minnesota Poll — was sadly predictable.
In a state with the only politically divided legislature, a proposal to allow consumers to buy into the publicly run MinnesotaCare program in lieu of private health insurance faced an uphill battle. DFL Gov. Tim Walz made this a marquee campaign issue, while Republicans saw it as expanding government's role in health care.
Now add in the bandwidth sucked up during the recent session by another vital health measure — continuing the state's provider tax, a critical funding source for medical assistance. The time and focus simply wasn't available to fully vet a transformative change like the buy-in and create the necessary political momentum.
This week, Walz's administration told an editorial writer that the work on the buy-in and other initiatives will continue and that it remains a key strategy to ensure that Minnesotans have affordable medical and drug coverage. The reassurance is especially welcome with so many other states embracing ambitious reforms.
Maintaining the provider tax, and extending another program called "reinsurance," merely kept the status quo in Minnesota. The state needs to pick up the pace if it is to remain a leader in health care innovation.
The action in other states this year is noteworthy, according to United States of Care, a Minnesota-based organization that monitors health initiatives and provides expertise to policymakers.
Consumer advocates, lawmakers, patients and governors have a growing appetite to solve problems on their own, said Joanna Dornfeld, the organization's senior director of state affairs. They're striking out on their own as gridlock stymies Congress and the Trump administration seeks to undermine, even eradicate, the Affordable Care Act.
A recent editorial in these pages highlighted a Colorado measure to cap out-of-pocket costs for insulin, a vital medication for diabetics, at $100 a month. But Colorado and a number of other states have also made a buy-in to public medical programs, or variations on it, a focus.